The global artificial organs and bionics market is projected to reach USD 100.31 billion by 2034, up from USD 44.98 billion in 2025, growing at a CAGR of 9.32% from 2025 to 2034. Rising transplant demand, innovations in 3D bioprinting, and AI-driven matching systems are propelling market expansion worldwide.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Organs and Bionics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Organs and Bionics Market Revenue and Volume, By Product
8.1.1 Artificial Organs
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Kidney
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Heart
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Lungs
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Liver
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Pancreas
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Artificial Bionics
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Cochlear Implant
8.1.8.1. Market Revenue and Volume Forecast
8.1.9. Exoskeleton
8.1.9.1. Market Revenue and Volume Forecast
8.1.10. Bionic Limbs
8.1.10.1. Market Revenue and Volume Forecast
8.1.11. Vision Bionics
8.1.11.1. Market Revenue and Volume Forecast
8.1.12. Vision Bionics
8.1.12.1. Market Revenue and Volume Forecast
9.1. Artificial Organs and Bionics Market Revenue and Volume, By Technology
9.1.1. Mechanical Bionics
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Electronic Bionics
9.1.2.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product
10.1.2. Market Revenue and Volume Forecast, By Technology
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product
10.1.3.2. Market Revenue and Volume Forecast, By Technology
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product
10.1.4.2. Market Revenue and Volume Forecast, By Technology
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product
10.2.2. Market Revenue and Volume Forecast, By Technology
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product
10.2.3.2. Market Revenue and Volume Forecast, By Technology
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product
10.2.4.2. Market Revenue and Volume Forecast, By Technology
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product
10.2.5.2. Market Revenue and Volume Forecast, By Technology
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product
10.2.6.2. Market Revenue and Volume Forecast, By Technology
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product
10.3.2. Market Revenue and Volume Forecast, By Technology
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product
10.3.3.2. Market Revenue and Volume Forecast, By Technology
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product
10.3.4.2. Market Revenue and Volume Forecast, By Technology
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product
10.3.5.2. Market Revenue and Volume Forecast, By Technology
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product
10.3.6.2. Market Revenue and Volume Forecast, By Technology
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product
10.4.2. Market Revenue and Volume Forecast, By Technology
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product
10.4.3.2. Market Revenue and Volume Forecast, By Technology
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product
10.4.4.2. Market Revenue and Volume Forecast, By Technology
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product
10.4.5.2. Market Revenue and Volume Forecast, By Technology
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product
10.4.6.2. Market Revenue and Volume Forecast, By Technology
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product
10.5.2. Market Revenue and Volume Forecast, By Technology
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product
10.5.3.2. Market Revenue and Volume Forecast, By Technology
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product
10.5.4.2. Market Revenue and Volume Forecast, By Technology
11.1. Medtronic Plc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Boston Scientific Corporation
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Zimmer Biomet
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Edwards Lifesciences Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Jarvik Heart, Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cochlear Ltd
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. SynCardia Systems, LLC
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Berlin Heart
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Ekso Bionics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. ABIOMED
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description